Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Updated Treatment Guidelines ! I hope we make 2025 list !

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Apr 14, 2024 11:11am

216 Views

Post# 35988176

RE:RE:RE:RE:Updated Treatment Guidelines ! I hope we make 2025 list !

Hopefully, the last one before BTD. However, if that drags on, how long can they keep doing these small raises? One or two more, or? The well will run dry one day. Not saying things will be delayed further, but they have had a tendency to do so in the past.. Unless the next update says otherwise, then perhaps Q2 is still where we get what we want. Would be a wonderful thing.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario